Skip to content

A Randomized Controlled Trial Comparing Selective Laser Trabeculoplasty and Timolol for Treatment of Glaucoma in Tanzania

A Randomized Controlled Trial Comparing Selective Laser Trabeculoplasty and Timolol for Treatment of Glaucoma in Tanzania

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR201508001235339
Enrollment
360
Registered
2015-08-12
Start date
2015-08-17
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eye Diseases Glaucoma

Interventions

Selective Laser Trabeculoplasty

Sponsors

London School of Hygiene & Tropical Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: IOP above 21mmHg in the study eye Open chamber angle with sufficient visualisation of angle structures (Shaffer II or more) on Gonioscopy Clear media (cornea, anterior chamber) to visualise the chamber angle Glaucomatous optic disc changes (structural changes due to glaucoma) with or without glaucomatous visual field defects (functional changes due to glaucoma) or high risk chronic open-angle glaucoma suspect. Ability to provide informed consent Willingness to return for regular follow-up visits Pseudophakic patients will be enrolled if the chamber angle is open and the anterior segment shows no signs of inflammation.

Exclusion criteria

Exclusion criteria: No perception of light History of previous glaucoma surgery including other laser treatment History of previous uveitis Neovascular glaucoma Physical inability to administer topical treatment Age below 18 years. Pregnant women History of asthma, bradycardia, previous heart failure, hypersensitivity to beta-blockers or systemic use of beta-blockers.

Design outcomes

Primary

MeasureTime frame
Success defined as intraocular pressure below or equal to target pressure

Secondary

MeasureTime frame
Success rates with fixed thresholds and mean intraocular pressure;Visual acuity and visual field;Complication rates;Quality of life and other patient reported outcomes;Cost analysis;Qualitative analysis;Structural changes of the optic disc, cornea or other affected structures
Structural changes of the optic disc, cornea or other affected structures;Success rates with fixed thresholds and mean intraocular pressure;Visual acuity and visual field;Complication rates;Quality of life and other patient reported outcomes;Cost analysis;Qualitative analysis

Countries

Tanzania

Contacts

Public ContactHeiko Philippin

Glaucoma Consultant

philippin@gmx.de+255 (0) 272754890

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 21, 2026